USS Investment Management Ltd Makes New Investment in HealthEquity, Inc. $HQY

HealthEquity logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • USS Investment Management bought 230,597 HealthEquity shares in the third quarter, worth about $20.4 million and representing roughly 0.28% of the company.
  • Institutional investors own 99.55% of HealthEquity. The company’s latest reported quarter beat analyst estimates for earnings and revenue, with revenue up 95.5% year over year.
  • Analysts’ consensus rating is “Moderate Buy,” with an average price target of $113.53; shares opened at $94.74.
  • MarketBeat previews the top five stocks to own by December 1st.

USS Investment Management Ltd bought a new stake in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund bought 230,597 shares of the company's stock, valued at approximately $20,404,000. USS Investment Management Ltd owned approximately 0.28% of HealthEquity as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors also recently modified their holdings of HQY. Maridea Wealth Management LLC acquired a new stake in shares of HealthEquity during the 2nd quarter valued at $2,753,000. Deutsche Bank AG acquired a new position in HealthEquity in the 2nd quarter worth about $11,986,000. Amundi increased its holdings in HealthEquity by 33.6% in the 2nd quarter. Amundi now owns 90,327 shares of the company's stock worth $8,158,000 after purchasing an additional 22,735 shares in the last quarter. Bamco Inc. NY bought a new position in HealthEquity in the second quarter valued at about $67,776,000. Finally, Oppenheimer Asset Management Inc. bought a new position in HealthEquity in the second quarter valued at about $21,079,000. Hedge funds and other institutional investors own 99.55% of the company's stock.

HealthEquity Price Performance

HealthEquity stock opened at $94.74 on Friday. The stock's 50 day moving average is $96.54 and its 200 day moving average is $90.35. HealthEquity, Inc. has a one year low of $72.76 and a one year high of $110.26. The firm has a market cap of $7.84 billion, a P/E ratio of 34.20, a P/E/G ratio of 1.65 and a beta of 0.22. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.99 and a quick ratio of 2.99.

HealthEquity (NASDAQ:HQY - Get Free Report) last released its earnings results on Thursday, August 27th. The company reported $1.24 earnings per share for the quarter, beating analysts' consensus estimates of $1.19 by $0.05. HealthEquity had a net margin of 17.36% and a return on equity of 15.33%. The business had revenue of $350.73 million during the quarter, compared to the consensus estimate of $349.22 million. The business's quarterly revenue was up 95.5% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 4.660-4.730 EPS. As a group, research analysts expect that HealthEquity, Inc. will post 3.94 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of analysts have recently commented on the company. BTIG Research reissued a "buy" rating and set a $115.00 price target on shares of HealthEquity in a research note on Friday, August 28th. Raymond James Financial reaffirmed a "strong-buy" rating on shares of HealthEquity in a research note on Thursday, September 3rd. Deutsche Bank raised their price objective on shares of HealthEquity from $135.00 to $142.00 and gave the company a "buy" rating in a report on Monday, August 31st. BMO Capital Markets lifted their target price on shares of HealthEquity from $105.00 to $125.00 and gave the stock an "outperform" rating in a research report on Wednesday, October 21st. Finally, Weiss Ratings downgraded HealthEquity from a "buy (b)" rating to a "buy (b-)" rating in a report on Tuesday. One equities research analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and one has given a Sell rating to the company's stock. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $113.53.

Check Out Our Latest Research Report on HQY

Insider Activity

In other news, Director Adrian Dillon sold 7,632 shares of the firm's stock in a transaction that occurred on Tuesday, August 25th. The shares were sold at an average price of $104.61, for a total transaction of $798,383.52. Following the completion of the sale, the director owned 62,395 shares of the company's stock, valued at $6,527,140.95. This trade represents a 10.90% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 1.60% of the company's stock.

HealthEquity Company Profile

(Free Report)

HealthEquity, Inc. provides technology and services for health savings accounts (HSAs) and other consumer-directed benefits. Its platform supports employers, health plans, benefits advisers and individuals in managing health-related accounts and benefits. Alongside HSAs, the company administers flexible spending accounts, health reimbursement arrangements, commuter benefits and other workplace benefit programs. Its services include account administration, payment tools, customer support and investment options for eligible HSA funds.

Further Reading

Institutional Ownership by Quarter for HealthEquity (NASDAQ:HQY)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in HealthEquity Right Now?

Before you consider HealthEquity, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HealthEquity wasn't on the list.

While HealthEquity currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

Oil still powers the global economy, but AI is reshaping the energy opportunity. Discover seven stocks spanning traditional energy, infrastructure, and next-generation power.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines